Comparison

FOLH1 Antibody (N-term) Blocking peptide

Item no. ABC-BP13707a
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Giusti, B., et al. Thromb. Haemost. 104(2):231-242(2010)Jugessur, A., et al. PLoS ONE 5 (7), E11493 (2010) :Mlcochova, P., et al. Prostate 69(5):471-479(2009)Davis, M.I., et al. Proc. Natl. Acad. Sci. U.S.A. 102(17):5981-5986(2005)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Similar products PSMA, FOLH1, PSM, FOLH, NAALAD1, Glutamate carboxypeptidase 2, Cell growth-inhibiting gene 27 protein, Folate hydrolase 1, Folylpoly-gamma-glutamate carboxypeptidase, Glutamate carboxypeptidase II, Membrane glutamate carboxypeptidase, FGCP, GCPII, mGCP, N-acetylated-alpha-linked acidic dipeptidase I, NAALADase I, Prostate-specific membrane antigen, Pteroylpoly-gamma-glutamate carboxypeptidase
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence used to generate the antibody AP13707a was selected from the N-term region of FOLH1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background
This gene encodes a type II transmembrane glycoproteinbelonging to the M28 peptidase family. The protein acts as aglutamate carboxypeptidase on different alternative substrates, including the nutrient folate and the neuropeptideN-acetyl-l-aspartyl-l-glutamate and is expressed in a number oftissues such as prostate, central and peripheral nervous system andkidney. A mutation in this gene may be associated with impairedintestinal absorption of dietary folates, resulting in low bloodfolate levels and consequent hyperhomocysteinemia. Expression ofthis protein in the brain may be involved in a number ofpathological conditions associated with glutamate excitotoxicity.In the prostate the protein is up-regulated in cancerous cells andis used as an effective diagnostic and prognostic indicator ofprostate cancer. This gene likely arose from a duplication event ofa nearby chromosomal region. Alternative splicing gives rise tomultiple transcript variants encoding several different isoforms.
Gene Name
FOLH1
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Manufacturer - Alias
Glutamate carboxypeptidase 2, Cell growth-inhibiting gene 27 protein, Folate hydrolase 1, Folylpoly-gamma-glutamate carboxypeptidase, FGCP, Glutamate carboxypeptidase II, GCPII, Membrane glutamate carboxypeptidase, mGCP, N-acetylated-alpha-linked acidic dipeptidase I, NAALADase I, Prostate-specific membrane antigen, PSM, PSMA, Pteroylpoly-gamma-glutamate carboxypeptidase, FOLH1, FOLH, NAALAD1, PSM, PSMA
Manufacturer - Similar
Glutamate carboxypeptidase 2, Cell growth-inhibiting gene 27 protein, Folate hydrolase 1, Folylpoly-gamma-glutamate carboxypeptidase, FGCP, Glutamate carboxypeptidase II, GCPII, Membrane glutamate carboxypeptidase, mGCP, N-acetylated-alpha-linked acidic dipeptidase I, NAALADase I, Prostate-specific membrane antigen, PSM, PSMA, Pteroylpoly-gamma-glutamate carboxypeptidase, FOLH1, FOLH, NAALAD1, PSM, PSMA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close